Literature DB >> 20405242

Solid focal liver lesions: dynamic and late enhancement patterns with the dual phase contrast agent gadobenate dimeglumine.

Luigi Grazioli1, Maria Pia Bondioni, Niccolò Faccioli, Sebastiana Gambarini, Rita Tinti, Günther Schneider, Miles Kirchin.   

Abstract

INTRODUCTION: The purpose of this paper is to illustrate contrast enhancement patterns of solid focal liver lesions on dynamic and late phase imaging with gadobenate dimeglumine (Gd-BOPTA). IMAGING
FINDINGS: Unenhanced T2- and T1-weighted, dynamic T1-weighted (arterial, portal-venous, and equilibrium) and late phase (1-3 h) Gd-BOPTA-enhanced MR imaging of different focal liver lesions (nodular regenerative hyperplasia, hepatic adenoma, liver adenomatosis, hepatocellular carcinoma, peripheral cholangiocarcinoma, hypervascular metastases, and hypovascular metastases) are shown. Dynamic imaging was performed using GRE T1-w sequences after the bolus injection of 0.1 mmol/kg Gd-BOPTA; late-phase imaging was obtained at 1-3 h after contrast injection.
CONCLUSIONS: Dynamic imaging with Gd-BOPTA provides the same information as with conventional gadolinium-based extracellular contrast agents, while late-phase imaging gives additional information for lesion identification and characterization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20405242     DOI: 10.1007/s12029-010-9145-0

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  43 in total

1.  Nodular regenerative hyperplasia of the liver. A review of 14 cases.

Authors:  M Arvanitaki; M Adler
Journal:  Hepatogastroenterology       Date:  2001 Sep-Oct

2.  Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation.

Authors:  Giuseppe Brancatelli; Michael P Federle; Luigi Grazioli; Rita Golfieri; Riccardo Lencioni
Journal:  AJR Am J Roentgenol       Date:  2002-04       Impact factor: 3.959

Review 3.  Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature.

Authors:  P Labrune; P Trioche; I Duvaltier; P Chevalier; M Odièvre
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-03       Impact factor: 2.839

Review 4.  Noncirrhotic portal hypertension: recent concepts.

Authors:  I R Wanless
Journal:  Prog Liver Dis       Date:  1996

5.  Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine.

Authors:  L Grazioli; G Morana; M P Federle; G Brancatelli; M Testoni; M A Kirchin; K Menni; L Olivetti; N Nicoli; C Procacci
Journal:  Radiology       Date:  2001-12       Impact factor: 11.105

6.  Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA).

Authors:  R Manfredi; G Maresca; R L Baron; A R Cotroneo; A M De Gaetano; A De Franco; G Pirovano; A Spinazzi; P Marano
Journal:  J Magn Reson Imaging       Date:  1999-05       Impact factor: 4.813

Review 7.  Focal liver lesions: MR imaging-pathologic correlation.

Authors:  C Bartolozzi; D Cioni; F Donati; R Lencioni
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

8.  Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI.

Authors:  Y Zhang; M Uchida; T Abe; H Nishimura; N Hayabuchi; Y Nakashima
Journal:  J Comput Assist Tomogr       Date:  1999 Sep-Oct       Impact factor: 1.826

9.  Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions.

Authors:  G Pirovano; A Vanzulli; L Marti-Bonmati; L Grazioli; R Manfredi; A Greco; N Holzknecht; H E Daldrup-Link; E Rummeny; B Hamm; V Arneson; L Imperatori; M A Kirchin; A Spinazzi
Journal:  AJR Am J Roentgenol       Date:  2000-10       Impact factor: 3.959

Review 10.  Hepatic metastases.

Authors:  K H Lewis; J L Chezmar
Journal:  Magn Reson Imaging Clin N Am       Date:  1997-05       Impact factor: 2.266

View more
  5 in total

Review 1.  Magnetic Resonanance Imaging of the Liver (Including Biliary Contrast Agents)-Part 2: Protocols for Liver Magnetic Resonanance Imaging and Characterization of Common Focal Liver Lesions.

Authors:  Andrea Agostini; Moritz F Kircher; Richard K G Do; Alessandra Borgheresi; Serena Monti; Andrea Giovagnoni; Lorenzo Mannelli
Journal:  Semin Roentgenol       Date:  2016-05-30       Impact factor: 0.800

2.  Low-dose gadobenate dimeglumine-enhanced MRI of the kidney for the differential diagnosis of localized renal lesions.

Authors:  Guenther Schneider; Thorsten Probst; Miles A Kirchin; Jonas Stroeder; Peter Fries; Arno Buecker
Journal:  Radiol Med       Date:  2015-06-19       Impact factor: 3.469

3.  Feasibility of 10-Minute Delayed Hepatocyte Phase Imaging Using a 30° Flip Angle in Gd-EOB-DTPA-Enhanced Liver MRI for the Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis or Cirrhosis.

Authors:  Inhwan Jeon; Eun-Suk Cho; Joo Hee Kim; Dae Jung Kim; Jeong-Sik Yu; Jae-Joon Chung
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 4.  Metal-Based Complexes as Pharmaceuticals for Molecular Imaging of the Liver.

Authors:  Julia Greiser; Wolfgang Weigand; Martin Freesmeyer
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-16

5.  A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver.

Authors:  Pei Nie; Guangjie Yang; Jian Guo; Jingjing Chen; Xiaoli Li; Qinglian Ji; Jie Wu; Jingjing Cui; Wenjian Xu
Journal:  Cancer Imaging       Date:  2020-02-24       Impact factor: 3.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.